• norsk
    • English
  • English 
    • norsk
    • English
  • Login
View Item 
  •   Home
  • Øvrige samlinger
  • Publikasjoner fra CRIStin - NTNU
  • View Item
  •   Home
  • Øvrige samlinger
  • Publikasjoner fra CRIStin - NTNU
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Enhanced expression of CXCL10 in inflammatory bowel disease: Potential role of mucosal toll-like 3 receptor stimulation

Østvik, Ann Elisabet; Granlund, Atle; Bugge, Marit; Nilsen, Nadra; Torp, Sverre Helge; Waldum, Helge; Damås, Jan Kristian; Espevik, Terje; Sandvik, Arne Kristian
Journal article
Submitted version
Thumbnail
View/Open
120420+CXCL10+artikkel-CEMIR.pdf (1.049Mb)
URI
http://hdl.handle.net/11250/2463728
Date
2013
Metadata
Show full item record
Collections
  • Institutt for klinisk og molekylær medisin [2657]
  • Publikasjoner fra CRIStin - NTNU [26751]
Original version
Inflammatory Bowel Diseases. 2013, 19 (2), 265-274.   10.1002/ibd.23034
Abstract
We explored the gene expression in colonic biopsies of active and inactive inflammatory bowel disease (IBD), in an extensive material of ulcerative colitis (UC) and Crohn`s disease (CD). The chemokine CXCL10 and its receptor CXCR3 were among the upregulated genes. This study examines the expression of CXCL10 and the mechanisms for its release in patients with UC or CD, and in intestinal epithelial cell (IEC) lines.

Methods: A microarray gene expression analysis was done on colonic biopsies (n= 133) from patients with IBD. Biopsies were studied with immunohistochemistry for CXCL10 and CXCR3 expression. Mechanisms for CXCL10 release in peripheral mononuclear cells (PBMCs) and in the colonic epithelial cell lines HT-29 and SW620 were studied upon pattern recognition receptor (PRR) stimulation.

Results: CXCL10 and CXCR3 mRNA abundances were increased in biopsies from active UC and CD compared to inactive disease and controls. CXCL10 was mainly localized to mucosal epithelial cells, with increased immunostaining in active IBD. CXCR3 positive cells were scattered in the lamina propria. CXCL10 was secreted from the colonic epithelial cell lines, in response to the toll-like receptor 3 (TLR3) ligand polyinosinic: polycytidylic acid (poly(I:C)). This ligand also induced a marked release of CXCL10 in PBMCs from IBD patients and controls.

Conclusions: We identify CXCL10 and CXCR3 as upregulated genes in colonic mucosa in active IBD. The TLR3-ligand poly(I:C) markedly increased release of CXCL10 in colonic epithelial cell lines, suggesting a TLR3 (dsRNA) mediated CXCL10 release from mucosal epithelial cells in IBD patients.
Publisher
Lippincott, Williams & Wilkins
Journal
Inflammatory Bowel Diseases

Contact Us | Send Feedback

Privacy policy
DSpace software copyright © 2002-2019  DuraSpace

Service from  Unit
 

 

Browse

ArchiveCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsDocument TypesJournalsThis CollectionBy Issue DateAuthorsTitlesSubjectsDocument TypesJournals

My Account

Login

Statistics

View Usage Statistics

Contact Us | Send Feedback

Privacy policy
DSpace software copyright © 2002-2019  DuraSpace

Service from  Unit